Related Experiment Video
Updated: Apr 19, 2026

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
Mutations in mitochondrial DNA and approaches for their correction
M V Patrushev1, P A Kamenski, I O Mazunin
1Faculty of Biology, Lomonosov Moscow State University, Moscow, 119991, Russia. peter@protein.bio.msu.ru.
Abstract:
Apart from the nucleus, the mitochondrion is the only organelle of an animal cell that contains its own genome. Mitochondrial DNA is much less in size than the nuclear one and codes for only several dozens of biological macromolecules. Nevertheless, mutations in mitochondrial genes often result in the occurrence of serious hereditary neuromuscular diseases. New mitochondrial DNA mutations and their relations to clinical symptoms are continuously reported in the scientific literature. In this review, we summarize existing data about such mutations, and also about contemporary gene therapy approaches that have been developed for their suppression.
Insights
Mitochondrial DNA mutations cause hereditary neuromuscular diseases. This review covers new mutations, their clinical links, and emerging gene therapy strategies for suppression.
Area of Science:
- Cell Biology
- Genetics
- Neurology
Background:
- Mitochondria possess their own genome, distinct from the nuclear DNA.
- Mitochondrial DNA (mtDNA) is small but mutations can lead to severe hereditary conditions.
- The link between novel mtDNA mutations and clinical symptoms is an active area of research.
Purpose of the Study:
- To review current knowledge on mitochondrial DNA mutations.
- To summarize the relationship between these mutations and clinical manifestations.
- To discuss advanced gene therapy approaches for treating mitochondrial diseases.
Main Methods:
- Literature review of scientific publications.
- Analysis of reported mitochondrial DNA mutations.
- Evaluation of gene therapy strategies for mtDNA-related disorders.
Main Results:
- Numerous mitochondrial DNA mutations are linked to hereditary neuromuscular diseases.
- Continuous discovery of new mutations and their associated clinical phenotypes.
- Development of gene therapy techniques shows promise for disease suppression.
Conclusions:
- Mitochondrial DNA mutations are significant contributors to neuromuscular disorders.
- Understanding genotype-phenotype correlations is crucial for diagnosis and treatment.
- Gene therapy offers a potential therapeutic avenue for mitochondrial diseases.
Related Concept Videos
Animal Mitochondrial Genetics
Mismatch Repair
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Genome Copying Errors

